A Nature Medicine review published in January 2026 described GLP-1 medicines as "being prescribed to growing numbers of patients worldwide" for an expanding list of indications and noted that "new, more effective molecules with optimised pharmacokinetics produce greater weight loss and some may be more effective for various metabolic disorders, through incorporation of one or more additional peptide epitopes." The clinical pipeline includes 39 GLP-1 receptor agonist drugs in development across 34 companies, with only seven coming from the top 20 pharmaceutical firms
Jain A, Subramanian R, Manohar B, Radha C (2019) Preparation, characterization and functional properties of Moringa oleifera seed protein isolate
10.1172/jci95147 J
Forbes 30 Under 30 Healthcare: Using AI To Improve Care And Cut Administrative Burdens When Eunice Wu, 26, worked as a pharmacist , she was frustrated by the endless and endlessly tedious data entry and administrative work her job entailed
doi: 10.1096/fj.11-203026
( D ) Immunoblotting of IR and IGF1R using antibodies specific for IR (sc-711, Santa Cruz Biotechnology Inc.) and IGF1R in lysates from WT, DKO, WT-IR, and L973F-IR preadipocytes